These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 18581511)

  • 1. Identifying risk for recurrent hepatocellular carcinoma after liver transplantation: implications for surveillance studies and new adjuvant therapies.
    Chan EY; Larson AM; Fix OK; Yeh MM; Levy AE; Bakthavatsalam R; Halldorson JB; Reyes JD; Perkins JD
    Liver Transpl; 2008 Jul; 14(7):956-65. PubMed ID: 18581511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent hepatocellular carcinoma after transplantation: use of a pathological score on explanted livers to predict recurrence.
    Parfitt JR; Marotta P; Alghamdi M; Wall W; Khakhar A; Suskin NG; Quan D; McAllister V; Ghent C; Levstik M; McLean C; Chakrabarti S; Garcia B; Driman DK
    Liver Transpl; 2007 Apr; 13(4):543-51. PubMed ID: 17394152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival outcomes in liver transplantation for hepatocellular carcinoma, comparing impact of hepatitis C versus other etiology of cirrhosis.
    Bozorgzadeh A; Orloff M; Abt P; Tsoulfas G; Younan D; Kashyap R; Jain A; Mantry P; Maliakkal B; Khorana A; Schwartz S
    Liver Transpl; 2007 Jun; 13(6):807-13. PubMed ID: 17539001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for fatal recurrence of hepatocellular carcinoma and their role in selecting candidates for liver transplantation.
    Zou WL; Zang YJ; Chen XG; Shen ZY
    Hepatobiliary Pancreat Dis Int; 2008 Apr; 7(2):145-51. PubMed ID: 18397848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver transplant for hepatocellular carcinoma: experience in a Saudi population.
    Allam N; Khalaf H; Fagih M; Al-Sebayel M
    Exp Clin Transplant; 2008 Mar; 6(1):14-24. PubMed ID: 18405240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver transplantation and recurrent hepatocellular carcinoma: predictive value of nodule size in a retrospective and explant study.
    Grasso A; Stigliano R; Morisco F; Martines H; Quaglia A; Dhillon AP; Patch D; Davidson BR; Rolles K; Burroughs AK
    Transplantation; 2006 Jun; 81(11):1532-41. PubMed ID: 16770242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-transplant therapy for hepatocellular carcinoma is associated with a lower recurrence after liver transplantation.
    Lao OB; Weissman J; Perkins JD
    Clin Transplant; 2009; 23(6):874-81. PubMed ID: 19453644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour size and differentiation in predicting recurrence of hepatocellular carcinoma after liver transplantation: external validation of a new prognostic score.
    Marelli L; Grasso A; Pleguezuelo M; Martines H; Stigliano R; Dhillon AP; Patch D; Davidson BR; Sharma D; Rolles K; Burroughs AK
    Ann Surg Oncol; 2008 Dec; 15(12):3503-11. PubMed ID: 18777193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of AFP mRNA-expressing cells in the peripheral blood for prediction of HCC recurrence after living donor liver transplantation.
    Marubashi S; Dono K; Nagano H; Sugita Y; Asaoka T; Hama N; Miyamoto A; Takeda Y; Umeshita K; Monden M
    Transpl Int; 2007 Jul; 20(7):576-82. PubMed ID: 17425725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prediction of risk of recurrence and time to recurrence of hepatocellular carcinoma after orthotopic liver transplantation: a pilot study.
    Marsh JW; Dvorchik I; Subotin M; Balan V; Rakela J; Popechitelev EP; Subbotin V; Casavilla A; Carr BI; Fung JJ; Iwatsuki S
    Hepatology; 1997 Aug; 26(2):444-50. PubMed ID: 9252157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Recurrence and metastasis of hepatocellular carcinoma after liver transplantation: single center experiences].
    Zheng SS; Chen J; Wang WL; Zhang M; Shen Y; Wu J; Xu X; Yan S
    Zhonghua Wai Ke Za Zhi; 2008 Nov; 46(21):1609-13. PubMed ID: 19094751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orthotopic liver transplantation for hepatocellular carcinoma: a thirteen-year single-center experience.
    Castroagudín JF; Molina E; Bustamante M; Tomé S; Otero E; Martínez J; Segade FR; Conde R; Varo E
    Transplant Proc; 2008 Nov; 40(9):2975-7. PubMed ID: 19010164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis of tumor recurrence after liver transplantation for hepatocellular carcinoma based on 1,198 cases.
    Sotiropoulos GC; Molmenti EP; Lösch C; Beckebaum S; Broelsch CE; Lang H
    Eur J Med Res; 2007 Oct; 12(10):527-34. PubMed ID: 18024261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HCV histological recurrence and survival following liver transplantation in patients with and without hepatocellular carcinoma.
    De Martin E; Senzolo M; Boninsegna S; Guido M; Masier A; Germani G; Tomat S; Brolese A; Neri D; Cillo U; Gambato M; Russo FP; Farinati F; Burra P
    Transplant Proc; 2008; 40(6):1974-5. PubMed ID: 18675104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of cell-cycle modulators to predict vascular invasion and recurrence after surgical treatment of hepatocellular carcinoma.
    Ramos E; Lladó L; Serrano T; Figueras A; Lastra R; Torras J; Figueras J; Rafecas A; Fabregat J
    Transplantation; 2006 Sep; 82(6):753-8. PubMed ID: 17006321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver transplantation for hepatocellular carcinoma under calcineurin inhibitors: reassessment of risk factors for tumor recurrence.
    Vivarelli M; Cucchetti A; La Barba G; Ravaioli M; Del Gaudio M; Lauro A; Grazi GL; Pinna AD
    Ann Surg; 2008 Nov; 248(5):857-62. PubMed ID: 18948815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved outcome of adult recipients with a high model for end-stage liver disease score and a small-for-size graft.
    Yi NJ; Suh KS; Lee HW; Shin WY; Kim J; Kim W; Kim YJ; Yoon JH; Lee HS; Lee KU
    Liver Transpl; 2009 May; 15(5):496-503. PubMed ID: 19399732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrence of hepatocellular carcinoma after liver transplant: patterns and prognosis.
    Roayaie S; Schwartz JD; Sung MW; Emre SH; Miller CM; Gondolesi GE; Krieger NR; Schwartz ME
    Liver Transpl; 2004 Apr; 10(4):534-40. PubMed ID: 15048797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microscopic vascular invasion detected by anti-CD34 immunohistochemistry as a predictor of recurrence of hepatocellular carcinoma after liver transplantation.
    Salizzoni M; Romagnoli R; Lupo F; David E; Mirabella S; Cerutti E; Ottobrelli A
    Transplantation; 2003 Sep; 76(5):844-8. PubMed ID: 14501865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver transplantation for hepatocellular carcinoma: results of a multicenter study with common priorization criteria.
    Santoyo J; Sanchez B; de la Mata M; Fernández-Aguilar JL; Lopez-Ciller P; Pascasio JM; Suarez MA; Gomez MA; Nogueras F; Muffak K; Cuende N; Alonso M
    Transplant Proc; 2009 Apr; 41(3):1009-11. PubMed ID: 19376412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.